Teleflex announced today that it entered into a definitive agreement to acquire Palette Life Sciences. The deal to acquire the privately-held urology technology developer includes an upfront cash payment of $600 million at closing. It also includes up to an additional $50 million upon the achievement of certain commercial milestones. Wayne, Pennsylvania-based Teleflex said in […]
Mergers & Acquisitions
Baxter names proposed kidney care spinoff ‘Vantive’
Baxter announced today that it picked “Vantive” as the name of its proposed kidney care spinoff. In January, Baxter announced plans to spin its renal care and acute therapies units into an independent, publicly traded company. It said at the time that it expected the company to stand alone in the next 12 to 18 […]
Johnson & Johnson looks to split off Kenvue, focus on MedTech and Pharma
Johnson & Johnson today announced its intention to split off at least 80.1% of the shares of Kenvue. The New Brunswick, New Jersey-based company plans for the separation of its former consumer health business to take place through an exchange offer. Kenvue completed its IPO in May 2023. Through the planned exchange offer, Johnson & […]
Inogen acquires French airway clearance tech developer Physio-Assist
Inogen (Nasdaq: INGN) announced today that it entered into a definitive agreement to acquire Physio-Assist. Physio-Assist, a France-based, privately-held company, develops and manufactures its Simeox technology. Simeox, which currently has availability outside the U.S., is a technology-enabled airway clearance device. It treats bronchiectasis, where the lung’s bronchi become damaged and widened. It often occurs in […]
Coloplast to acquire wound care company Kerecis for $1.3B
Coloplast announced today that it entered into an agreement to sign Kerecis, a developer of biologics for the wound care market. The agreement has a total value reaching up to $1.3 billion. Of that, Coloplast intends to pay $1.2 billion in an upfront cash payment. Denmark-based Coloplast sees Kerecis as an “attractive opportunity” to strengthen […]
ResMed acquires respiratory diagnostics software developer Somnoware
ResMed announced that it acquired respiratory care diagnostics software developer Somnoware. This move marks the second software buy in the past year for ResMed. The San Diego-based sleep respiratory treatment maker bought Medifox Dan for $1 billion in November 2022. Medifox Dan develops clinical, financial and operational software for out-of-hospital care providers. It offers care […]
Bausch + Lomb makes another eye drop acquisition
Bausch + Lomb (NYSE:BLCO) announced today that an affiliate purchased the Blink product line from Johnson & Johnson Vision. The over-the-counter Blink product line features eye and contact lens drops, marking another eye care acquisition for Bausch + Lomb. Last week, the company acquired eye drops and a delivery system from Novartis in a deal worth up to […]
Bausch + Lomb acquires XIIDRA eye drops, delivery system from Novartis in $2.5B deal
Bausch + Lomb (NYSE:BLCO) announced today that it agreed to acquire XIIDRA non-steroid eye drops from Novartis. The company also acquired an investigational medicine and rights to a delivery device for treating dry eye disease (DED). AcuStream, an investigational device that may have the potential to facilitate precise dosing and accurate delivery of certain topical […]
Enovis completes Novastep acquisition
Enovis (NYSE: ENOV) announced today that it has completed its purchase of Novastep and its foot and ankle minimally invasive surgical (MIS) platform. The financial terms of the deal were undisclosed. Novastep generates about $20 million in annual revenue. “We are excited to welcome Novastep’s talented team to Enovis where we will work together to develop […]
Restor3d to acquire Conformis for $2.27 per share
Restor3d and Conformis (Nasdaq:CFMS) announced that they entered into a definitive merger agreement. Under the agreement, Restor3d, a 3D-printed orthopedic implants company, acquires all outstanding shares of Conformis common stock. The deal includes a purchase price of $2.27 per share. That represents a 96% premium to the closing price on June 22, 2023. Restor3d intends […]
Surgalign files Chapter 11 to sell global hardware, biologics business
Surgalign (Nasdaq:SRGA) announced today that it entered into an agreement to sell assets under a Chapter 11 bankruptcy. The asset purchase agreement enables Surgalign to sell substantially all U.S. hardware and biomaterial assets. It also intends to sell the equity interests in non-debtor entities related to the debtors’ hardware business outside the U.S. — Xtant […]